Type I Transforming Growth Factor Β Receptor Binds to and Activates Phosphatidylinositol 3-Kinase

Journal of Biological Chemistry - United States
doi 10.1074/jbc.m413223200
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

Differential Requirement for Type I and Type II Transforming Growth Factor Β Receptor Kinase Activity in Ligand-Mediated Receptor Endocytosis

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1998English

Inhibition of Pulmonary and Skeletal Metastasis by a Transforming Growth Factor-Β Type I Receptor Kinase Inhibitor

Cancer Research
Cancer ResearchOncology
2006English

Dihydropyrrolopyrazole Transforming Growth Factor-B Type I Receptor Kinase Domain Inhibitors: A Novel Benzimidazole Series With Selectivity Versus Transforming Growth Factor-B Type II Receptor Kinase and Mixed Lineage Kinase-7

English

Antiapoptotic Signalling by the Insulin-Like Growth Factor I Receptor, Phosphatidylinositol 3-Kinase, and Akt.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1997English

Influenza a Virus NS1 Protein Binds P85beta and Activates Phosphatidylinositol-3-Kinase Signaling

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2006English

Multiple and Essential Sp1 Binding Sites in the Promoter for Transforming Growth Factor-Β Type I Receptor

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1997English

In the Absence of Type III Receptor, the Transforming Growth Factor (TGF)-β Type II-B Receptor Requires the Type I Receptor to Bind TGF-β2

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2004English

Transforming Growth Factor-Β Receptor 1 (TGFBR1; ALK5)

Science-Business eXchange
2008English

Transforming Growth Factor Β

2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy